| Primary information |
|---|
| CancerPDF_ID | CancerPDF_ID1185 |
| PMID | 21082738 |
| Peptide Sequence | NA |
| Peptide Sequence in Publication | NA |
| Protein Name | NA |
| UniprotKB Entry Name | NA |
| Biofluid | Serum |
| M/Z | 6389.3 |
| Charge | NA |
| Mass/H+ | NA |
| Mass (in Daltons) | NA |
| Profiling Technique | MALDI-TOF |
| Peptide Identification Technique | NA |
| Quantification Technique | NA |
| Labeling | Label Free |
| FDR | NA |
| p-Value | 1.00E-06 |
| Software | ClinProTools |
| Length of Peptide | NA |
| Cancer Type | Lung cancer |
| Database for Peptide search | NA |
| Modification | NA |
| Number of Patients | "64 lung cancer patients ie 52 nonsmall cell lung cancer patients and 12 small cell lung cancer patients (32 for training set and 32 for testingset), 64 healthy controls (32 for training set and 32 for testing set), and 10 COPD patients (for disease control)" |
| Regulation/Differential Expression | Downregulated in cancer vs normal with average expression of peptide in cancer 0.61 and in normal 0.98 |
| Validation | Independent Validation |
| Sensitivity | For testing data 87% |
| Specificity | For testing data 84.8% |
| Accuracy | NA |
| Secondary information |
|---|
| Peptide Atlas | NA |
| IEDB | |